1. Home
  2. DPRO vs BNR Comparison

DPRO vs BNR Comparison

Compare DPRO & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Draganfly Inc.

DPRO

Draganfly Inc.

HOLD

Current Price

$6.64

Market Cap

230.7M

Sector

Industrials

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$18.77

Market Cap

252.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DPRO
BNR
Founded
1998
2014
Country
Canada
China
Employees
N/A
N/A
Industry
Aerospace
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
230.7M
252.7M
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
DPRO
BNR
Price
$6.64
$18.77
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$15.67
N/A
AVG Volume (30 Days)
1.9M
16.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$42.16
$136.32
Revenue Next Year
$145.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.63
$2.18
52 Week High
$14.37
$41.72

Technical Indicators

Market Signals
Indicator
DPRO
BNR
Relative Strength Index (RSI) 46.34 35.76
Support Level $6.23 $7.99
Resistance Level $7.15 $24.23
Average True Range (ATR) 0.50 1.98
MACD 0.03 -0.57
Stochastic Oscillator 40.92 26.12

Price Performance

Historical Comparison
DPRO
BNR

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: